The QMN Weekly Bulletin
Pharmaceuticals / Regulatory Affairs

European Expert Details Common GMP Inspection Findings

Nov. 22, 2013
A A
The European Medicines Agency (EMA) recently conducted an investigation into the root causes for recalls and quality defects. The agency unearthed some startling results. EMA official David Cockburn detailed the project, which is still ongoing, during a session at last month’s 2013 Regulatory Affairs Professionals Society’s annual meeting in Boston. One of the most common causes was missing or incorrect information in product leaflets.
Drug GMP Report